{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:38:05Z","timestamp":1790973485012,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000971","name":"Amyotrophic Lateral Sclerosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1NS041680"],"award-info":[{"award-number":["RO1NS041680"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.expneurol.2006.03.028","type":"journal-article","created":{"date-parts":[[2006,6,7]],"date-time":"2006-06-07T17:13:22Z","timestamp":1149700402000},"page":"120-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice"],"prefix":"10.1016","volume":"201","author":[{"given":"Andrea C.","family":"Pardo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M.","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Dykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohichi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D.","family":"Rothstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J.","family":"Maragakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2006.03.028_bib1","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1046\/j.1471-4159.2000.0741666.x","article-title":"Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu\/Zn superoxide dismutase","volume":"74","author":"Alexander","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.03.028_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1471-4159.2001.00572.x","article-title":"Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels","volume":"79","author":"Bendotti","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2006.03.028_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.410390519","article-title":"Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex","volume":"39","author":"Bristol","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0896-6273(00)80272-X","article-title":"ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions","volume":"18","author":"Bruijn","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2006.03.028_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.03.028_bib6","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35097565","article-title":"From charcot to lou gehrig: deciphering selective motor neuron death in als","volume":"2","author":"Cleveland","year":"2001","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1528-1157.2002.35001.x","article-title":"Increased expression of the neuronal glutamate transporter (EAAT3\/EAAC1) in hippocampal and neocortical epilepsy","volume":"43","author":"Crino","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.expneurol.2006.03.028_bib8","first-page":"1271","article-title":"Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis","volume":"145","author":"Dal Canto","year":"1994","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10374","article-title":"Cyclooxygenase 2 inhibition protects motor neurons and prolongs survival in a transgenic mouse model of ALS","volume":"52","author":"Drachman","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib10","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1523\/JNEUROSCI.23-05-01688.2003","article-title":"Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis","volume":"23","author":"Dunlop","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/ana.1029","article-title":"Intron 7 retention and exon 9 skipping EAAT2 mRNA variants are not associated with amyotrophic lateral sclerosis","volume":"49","author":"Flowers","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib12","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1523\/JNEUROSCI.20-02-00660.2000","article-title":"Restricted expression of G86R Cu\/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration","volume":"20","author":"Gong","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib13","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1093\/hmg\/ddg267","article-title":"Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice","volume":"12","author":"Guo","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2006.03.028_bib14","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.03.028_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.410390203","article-title":"Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis","volume":"39","author":"Gurney","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2005.02.006","article-title":"Background and gender effects on survival in the TgN (SOD1-G93A)1Gur mouse model of ALS","author":"Heiman-Patterson","year":"2005","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib17","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1212\/WNL.55.8.1082","article-title":"Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls","volume":"55","author":"Honig","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.028_bib18","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.032539299","article-title":"Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)","volume":"99","author":"Howland","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2006.03.028_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/j.1749-6632.2005.tb00034.x","article-title":"Late-onset motoneuron disease caused by a functionally modified AMPA receptor subunit","author":"Kuner","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2006.03.028_bib20","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","article-title":"Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease","volume":"22","author":"Lino","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuron.2004.06.016","article-title":"Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria","volume":"43","author":"Liu","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2006.03.028_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.nbd.2003.12.007","article-title":"Glutamate transporters: animal models to neurologic disease","volume":"15","author":"Maragakis","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2006.03.028_bib23","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/ana.20003","article-title":"Altered expression of the glutamate transporter EAAT2b in neurological disease","volume":"55","author":"Maragakis","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1212\/WNL.52.3.453","article-title":"Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy","volume":"52","author":"Mathern","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2006.03.028_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0022-510X(99)00196-3","article-title":"The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals","volume":"170","author":"Meyer","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib26","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1523\/JNEUROSCI.23-18-07176.2003","article-title":"Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1","volume":"23","author":"Mitani","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib27","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1073\/pnas.92.4.954","article-title":"Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons","volume":"92","author":"Pardo","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2006.03.028_bib28","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","article-title":"Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment","volume":"21","author":"Pramatarova","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib29","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/ana.410280106","article-title":"Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis","volume":"28","author":"Rothstein","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0896-6273(94)90038-8","article-title":"Localization of neuronal and glial glutamate transporters","volume":"13","author":"Rothstein","year":"1994","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2006.03.028_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2006.03.028_bib32","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2006.03.028_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta\u2013lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2006.03.028_bib34","first-page":"21","article-title":"Epilepsy and exacerbation of brain injury in mice lacking glutamate transporter GLT-1 (Vol 276, pg 1699, 1997)","volume":"278","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2006.03.028_bib35","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0306-4522(00)00485-1","article-title":"Role of excitatory amino acid transporter 1 in neonatal rat neuronal damage induced by hypoxia\u2013ischemia","volume":"102","author":"Tao","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2006.03.028_bib36","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/8091","article-title":"SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter [In Process Citation]","volume":"2","author":"Trotti","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2006.03.028_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0304-3940(03)00314-8","article-title":"The AMPA receptor antagonist NBQX prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"343","author":"Van Damme","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2006.03.028_bib38","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0006-8993(99)01945-9","article-title":"Amygdala-kindled and pentylenetetrazole-induced seizures in glutamate transporter GLAST-deficient mice","volume":"845","author":"Watanabe","year":"1999","journal-title":"Brain Res."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488606002457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:33:52Z","timestamp":1758000832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488606002457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0014488606002457"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.03.028","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2006.03.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}